Article Details

Caladrius Biosciences (NASDAQ:CLBS) Rating Lowered to Sell at Zacks Investment Research

Retrieved on: 2021-01-22 11:15:00

Tags for this article:

Click the tags to see associated articles and topics

Caladrius Biosciences (NASDAQ:CLBS) Rating Lowered to Sell at Zacks Investment Research. View article details on hiswai:

Excerpt

Acadian Asset Management LLC raised its holdings in shares of Caladrius Biosciences, Inc. (NASDAQ:CLBS) by 119.0% in the 3rd quarter, according ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up